Susan  Molineaux net worth and biography

Susan Molineaux Biography and Net Worth

Dr. Molineaux is the co-founder, President and CEO of Calithera Biosciences, a start-up company that commenced operations in June of 2010. Prior to starting Calithera, Dr. Molineaux was a co-founder of Proteolix and served as the CSO for two years before becoming President and CEO of the company. Proteolix was acquired by Onyx Pharmaceuticals in November 2009. Prior to joining Proteolix, Dr. Molineaux was Vice President of Biology at Rigel Pharmaceuticals from 2000 to 2003. Before that, she was Vice President of Biology at Praelux, and from 1994 through 1999, Dr. Molineaux served as Vice President of Drug Development at Praecis Pharmaceuticals. From 1989 until 1994 she was a scientist in the immunology group at Merck, in Rahway, NJ.

Education:
B.S. in Biology from Smith College
Ph.D. in Molecular Biology from Johns Hopkins University
Postdoctoral fellowship at Columbia University

How old is Susan Molineaux?

Dr. Molineaux is currently 70 years old. There are 2 older executives and no younger executives at Calithera Biosciences. Learn More on Susan Molineaux's age.

How do I contact Susan Molineaux?

The corporate mailing address for Dr. Molineaux and other Calithera Biosciences executives is 343 OYSTER POINT BLVD. SUITE 200, SOUTH SAN FRANCISCO CA, 94080. Calithera Biosciences can also be reached via phone at (650) 870-1000 and via email at [email protected]. Learn More on Susan Molineaux's contact information.

Has Susan Molineaux been buying or selling shares of Calithera Biosciences?

Susan Molineaux has not been actively trading shares of Calithera Biosciences during the last quarter. Most recently, on Wednesday, November 10th, Susan Molineaux bought 100,000 shares of Calithera Biosciences stock. The stock was acquired at an average cost of $0.85 per share, with a total value of $85,000.00. Learn More on Susan Molineaux's trading history.

Who are Calithera Biosciences' active insiders?

Calithera Biosciences' insider roster includes Susan Molineaux (CEO), and Keith Orford (Director). Learn More on Calithera Biosciences' active insiders.

Susan Molineaux Insider Trading History at Calithera Biosciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/10/2021Buy100,000$0.85$85,000.00View SEC Filing Icon  
6/25/2019Buy51,600$3.88$200,208.00View SEC Filing Icon  
See Full Table

Susan Molineaux Buying and Selling Activity at Calithera Biosciences

This chart shows Susan Molineaux's buying and selling at Calithera Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Calithera Biosciences Company Overview

Calithera Biosciences logo
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $0.02
Low: $0.02
High: $0.02

50 Day Range

MA: $0.03
Low: $0.02
High: $0.03

2 Week Range

Now: $0.02
Low: $0.01
High: $0.50

Volume

163 shs

Average Volume

1,601 shs

Market Capitalization

$119,802.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A